{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T03:05:27Z","timestamp":1778987127338,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":558,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI115714"],"award-info":[{"award-number":["U01AI115714"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1111\/ajt.16427","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T03:00:06Z","timestamp":1607137206000},"page":"1780-1788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV\/HCV-coinfected participants with decompensated liver disease pre\u2013 or post\u2013liver transplant"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1484-4752","authenticated-orcid":false,"given":"Marion G.","family":"Peters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Kottilil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4143-1950","authenticated-orcid":false,"given":"Norah","family":"Terrault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Amara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Husson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirish","family":"Huprikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander","family":"Florman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2605-9257","authenticated-orcid":false,"given":"Christine M.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne F.","family":"Luetkemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Grab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandy","family":"Haydel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Blumberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Dove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Emond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Olthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coleman","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Masur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5806-0167","authenticated-orcid":false,"given":"Peter G.","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1111\/ajt.16427_bib1","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/hep.27553","article-title":"Human immunodeficiency virus and liver transplantation: Hepatitis C is the last hurdle","volume":"61","author":"Stock","year":"2015","journal-title":"Hepatology."},{"issue":"1","key":"10.1111\/ajt.16427_bib2","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2468-2667(16)30020-2","article-title":"Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort","volume":"2","author":"Croxford","year":"2017","journal-title":"Lancet Public Health."},{"issue":"3","key":"10.1111\/ajt.16427_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jhep.2014.10.032","article-title":"Outcome and management of HCV\/HIV coinfection pre- and post-liver transplantation. A 2015 update","volume":"62","author":"Miro","year":"2015","journal-title":"J Hepatol."},{"issue":"11","key":"10.1111\/ajt.16427_bib4","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1136\/gutjnl-2015-309300","article-title":"Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B","volume":"66","author":"Bayliss","year":"2017","journal-title":"Gut."},{"issue":"3","key":"10.1111\/ajt.16427_bib5","first-page":"223","article-title":"Liver transplantation in HIV-seropositive individuals","volume":"144","author":"Ragni","year":"2006","journal-title":"AnnIntern Med."},{"issue":"10","key":"10.1111\/ajt.16427_bib6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","volume":"67","author":"Hepatitis","year":"2018","journal-title":"Clin Infect Dis."},{"issue":"1","key":"10.1111\/ajt.16427_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11904-010-0071-3","article-title":"HIV\/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies","volume":"8","author":"Operskalski","year":"2011","journal-title":"Curr HIV\/AIDS Rep."},{"issue":"5","key":"10.1111\/ajt.16427_bib8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1600-6143.2010.03070.x","article-title":"Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients","volume":"10","author":"Coffin","year":"2010","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.16427_bib9","doi-asserted-by":"crossref","unstructured":"de Vera ME, Dvorchik I, Tom K, et al. Survival of Liver Transplant Patients Coinfected with HIV and HCV Is Adversely Impacted by Recurrent Hepatitis C. Am J Transplant. 2006.","DOI":"10.1111\/j.1600-6143.2006.01546.x"},{"issue":"6","key":"10.1111\/ajt.16427_bib10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/lt.23411","article-title":"Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection","volume":"18","author":"Terrault","year":"2012","journal-title":"Liver Transpl."},{"issue":"2","key":"10.1111\/ajt.16427_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology."},{"issue":"6","key":"10.1111\/ajt.16427_bib12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology."},{"issue":"2","key":"10.1111\/ajt.16427_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","article-title":"The survival benefit of liver transplantation","volume":"5","author":"Merion","year":"2005","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.16427_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(16)00052-9","article-title":"Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial","volume":"16","author":"Manns","year":"2016","journal-title":"Lancet Infect Dis."},{"issue":"8","key":"10.1111\/ajt.16427_bib15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1501315","article-title":"Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1","volume":"373","author":"Naggie","year":"2015","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1111\/ajt.16427_bib16","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/jac\/dkx223","article-title":"Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV\/HIV-coinfected patients","volume":"72","author":"Navarro","year":"2017","journal-title":"J Antimicrob Chemother."},{"issue":"6","key":"10.1111\/ajt.16427_bib17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/09540121.2019.1645808","article-title":"Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 study","volume":"32","author":"Piekarska","year":"2020","journal-title":"AIDS Care."},{"issue":"1","key":"10.1111\/ajt.16427_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/QAI.0000000000001342","article-title":"Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV\/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort","volume":"75","author":"Lacombe","year":"2017","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"3","key":"10.1111\/ajt.16427_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3851\/IMP3108","article-title":"Daclatasvir plus sofosbuvir, with or without ribavirin, in real-world patients with HIV-HCV coinfection and advanced liver disease","volume":"22","author":"Rockstroh","year":"2017","journal-title":"Antivir Ther."},{"issue":"3","key":"10.1111\/ajt.16427_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology."},{"issue":"10","key":"10.1111\/ajt.16427_bib21","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/cid\/ciz601","article-title":"Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment","volume":"70","author":"Mocroft","year":"2020","journal-title":"Clin Infect Dis."},{"issue":"5","key":"10.1111\/ajt.16427_bib22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/2050640619840149","article-title":"Hepatitis C virus therapy in advanced liver disease: Outcomes and challenges","volume":"7","author":"Ekpanyapong","year":"2019","journal-title":"United European Gastroenterol J."},{"key":"10.1111\/ajt.16427_bib23","doi-asserted-by":"crossref","unstructured":"Corma-G\u00f3mez A, Mac\u00edas J, Lacalle-Remigio JR, et al. HIV infection is associated with lower risk of hepatocellular carcinoma after sustained virological response to direct-acting antivirals in hepatitis C infected-patients with advanced fibrosis. Clin Infect Dis. 2020.","DOI":"10.1093\/cid\/ciaa1111"},{"issue":"4","key":"10.1111\/ajt.16427_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/jvh.13245","article-title":"Transient elastography in DAA era. Relation between post-SVR LSM and histology","volume":"27","author":"Mart\u00ednez-Campreci\u00f3s","year":"2020","journal-title":"J Viral Hepat."},{"issue":"3","key":"10.1111\/ajt.16427_bib25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jhep.2020.03.031","article-title":"DAA therapy and long-term hepatic function in advanced\/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort","volume":"73","author":"Verna","year":"2020","journal-title":"J Hepatol."},{"issue":"10","key":"10.1111\/ajt.16427_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224523","article-title":"CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro","volume":"14","author":"Blackard","year":"2019","journal-title":"PLoS One."},{"issue":"9","key":"10.1111\/ajt.16427_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13499","article-title":"Solid organ transplantation in the HIV-infected patient: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Blumberg","year":"2019","journal-title":"Clin Transplant."},{"issue":"5","key":"10.1111\/ajt.16427_bib28","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/TP.0000000000001708","article-title":"International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates","volume":"101","author":"Terrault","year":"2017","journal-title":"Transplantation."},{"issue":"10","key":"10.1111\/ajt.16427_bib29","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1111\/ajt.14996","article-title":"Direct-acting antivirals are effective and safe in HCV\/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study","volume":"18","author":"Manzardo","year":"2018","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.16427_bib30","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/lt.24505","article-title":"Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3\/F4) after liver transplantation","volume":"22","author":"Dumortier","year":"2016","journal-title":"Liver Transpl."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16427","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.16427","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522085410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522085410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:33:45Z","timestamp":1761629625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522085410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1600613522085410"],"URL":"https:\/\/doi.org\/10.1111\/ajt.16427","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV\/HCV-coinfected participants with decompensated liver disease pre\u2013 or post\u2013liver transplant","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.16427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}